Related Experiment Video
Updated: Jul 19, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
[Statins (HMG-CoA reductase inhibitors)]
1Department of Clinical and Molecular Epidemiology, Graduate School of Medicine, University of Tokyo.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|November 8, 2006
Summary
Diabetic patients often have abnormal lipid profiles, increasing coronary heart disease risk. More aggressive lipid-lowering treatment is needed for Japanese diabetic patients with hyperlipidemia.
Area of Science:
- Endocrinology and Metabolism
- Cardiovascular Disease Research
- Pharmacology
Context:
- Diabetic patients exhibit frequent lipid abnormalities, elevating coronary heart disease (CHD) risk.
- Clinical guidelines advocate for aggressive lipid lowering in diabetic patients with hyperlipidemia.
- Lipid-lowering agents, especially statins, have proven effective in reducing CHD risk in this population.
Purpose:
- To assess the prevalence of hyperlipidemia in Japanese diabetic patients.
- To evaluate the current utilization of lipid-lowering agents among these patients.
- To determine the need for more intensive treatment strategies.
Summary:
- Investigation of 9,000 Japanese diabetic patients revealed hyperlipidemia in approximately half.
- Less than half of hyperlipidemic diabetic patients were receiving lipid-lowering therapy.
- Findings indicate a gap in recommended treatment intensity.
Impact:
- Highlights the under-treatment of hyperlipidemia in Japanese diabetic patients.
- Suggests a need for enhanced clinical interventions and guideline adherence.
- Emphasizes the importance of aggressive lipid management to mitigate cardiovascular risk in diabetes.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:27Phase I Reactions: Reductive Reactions
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...